TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m

Mario Eisenberger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.